Mark Samuels

5.4k total citations · 2 hit papers
48 papers, 3.2k citations indexed

About

Mark Samuels is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, Mark Samuels has authored 48 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 14 papers in Genetics and 5 papers in Surgery. Recurrent topics in Mark Samuels's work include RNA Research and Splicing (11 papers), RNA and protein synthesis mechanisms (10 papers) and Extracellular vesicles in disease (7 papers). Mark Samuels is often cited by papers focused on RNA Research and Splicing (11 papers), RNA and protein synthesis mechanisms (10 papers) and Extracellular vesicles in disease (7 papers). Mark Samuels collaborates with scholars based in United States, United Kingdom and Canada. Mark Samuels's co-authors include Phillip A. Sharp, Andrew Fire, Paul Schedl, James L. Manley, Lewis A. Chodosh, Thomas W. Cline, Paul N. Hopkins, Duane L. Guernsey, Mark H. Skolnick and Marie‐Pierre Dubé and has published in prestigious journals such as Cell, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Mark Samuels

46 papers receiving 3.1k citations

Hit Papers

[35] In Vitro transcription: Whole-cell extract 1982 2026 1996 2011 1983 1982 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. [35] In Vitro transcription: Whole-cell extract
    1983 286 citations Andrew Fire, Mark Samuels et al. profile →
  2. Separation and characterization of factors mediating accurate transcription by RNA polymerase II.
    1982 283 citations Mark Samuels, Andrew Fire et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Samuels United States 27 2.4k 779 379 246 226 48 3.2k
Stefan G. E. Roberts United Kingdom 28 3.2k 1.3× 761 1.0× 298 0.8× 283 1.2× 323 1.4× 75 4.0k
Angabin Matin United States 20 1.5k 0.6× 772 1.0× 287 0.8× 231 0.9× 152 0.7× 43 2.6k
Vivek Iyer United Kingdom 17 2.1k 0.9× 651 0.8× 106 0.3× 270 1.1× 249 1.1× 31 2.9k
Jonathan D. Chesnut United States 22 2.1k 0.9× 492 0.6× 139 0.4× 242 1.0× 89 0.4× 38 2.4k
R. E. K. Fournier United States 34 3.0k 1.3× 1.2k 1.5× 320 0.8× 301 1.2× 329 1.5× 91 3.9k
Roger G. Clerc Switzerland 17 2.2k 0.9× 518 0.7× 267 0.7× 461 1.9× 765 3.4× 21 3.0k
Chul Geun Kim South Korea 28 2.4k 1.0× 616 0.8× 152 0.4× 381 1.5× 215 1.0× 120 3.1k
Francis James Grant United States 22 1.5k 0.6× 373 0.5× 335 0.9× 128 0.5× 352 1.6× 33 3.1k
Izuho Hatada Japan 32 2.9k 1.2× 879 1.1× 180 0.5× 608 2.5× 155 0.7× 88 3.5k
Vasily Ramensky Russia 15 1.7k 0.7× 986 1.3× 160 0.4× 199 0.8× 131 0.6× 39 2.5k

Countries citing papers authored by Mark Samuels

Since Specialization
Citations

This map shows the geographic impact of Mark Samuels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Samuels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Samuels more than expected).

Fields of papers citing papers by Mark Samuels

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Samuels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Samuels. The network helps show where Mark Samuels may publish in the future.

Co-authorship network of co-authors of Mark Samuels

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Samuels. A scholar is included among the top collaborators of Mark Samuels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Samuels. Mark Samuels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Robinson, Stephen, et al.. (2025). Spatial biology – unravelling complexity within the glioblastoma microenvironment. Trends in Molecular Medicine. 31(9). 846–859. 2 indexed citations
2.
3.
Samuels, Mark, et al.. (2025). CRISPR screening approaches in breast cancer research. Cancer and Metastasis Reviews. 44(3). 59–59.
4.
Samuels, Mark & Georgios Giamas. (2024). MISEV2023: Shaping the Future of EV Research by Enhancing Rigour, Reproducibility and Transparency. Cancer Gene Therapy. 31(5). 649–651. 6 indexed citations
5.
6.
Samuels, Mark, et al.. (2023). The role of non-coding RNAs in extracellular vesicles in breast cancer and their diagnostic implications. Oncogene. 42(41). 3017–3034. 15 indexed citations
7.
Papakyriakou, Athanasios, Mark Samuels, Panagiotis Papanastasopoulos, et al.. (2023). The Inhibitory Properties of a Novel, Selective LMTK3 Kinase Inhibitor. International Journal of Molecular Sciences. 24(1). 865–865. 5 indexed citations
8.
Mampay, Myrthe, Marcus Allen, Mark Samuels, et al.. (2023). Propranolol reduces IFN-γ driven PD-L1 immunosuppression and improves anti-tumour immunity in ovarian cancer. Brain Behavior and Immunity. 110. 1–12. 22 indexed citations
9.
Cilibrasi, Chiara, Thomas R. Simon, Christos Tolias, et al.. (2022). Definition of an Inflammatory Biomarker Signature in Plasma-Derived Extracellular Vesicles of Glioblastoma Patients. Biomedicines. 10(1). 125–125. 21 indexed citations
10.
Samuels, Mark, et al.. (2022). Incorporating Immunotherapy in the Management of Gastric Cancer: Molecular and Clinical Implications. Cancers. 14(18). 4378–4378. 6 indexed citations
11.
Samuels, Mark, et al.. (2014). Goliath, a Variant of DAVID Syndrome?. 1 indexed citations
12.
13.
Orr, Andrew, Marie‐Pierre Dubé, Juan Carlos Zenteno, et al.. (2011). Mutations in a novel serine protease PRSS56 in families with nanophthalmos.. PubMed. 17. 1850–61. 43 indexed citations
14.
Robitaille, Johane M., Karin Wallace, M Beis, et al.. (2009). Phenotypic Overlap of Familial Exudative Vitreoretinopathy (FEVR) with Persistent Fetal Vasculature (PFV) Caused byFZD4Mutations in two Distinct Pedigrees. Ophthalmic Genetics. 30(1). 23–30. 48 indexed citations
15.
Brinkman, Ryan R., Marie‐Pierre Dubé, Guy A. Rouleau, Andrew Orr, & Mark Samuels. (2006). Human monogenic disorders — a source of novel drug targets. Nature Reviews Genetics. 7(4). 249–260. 68 indexed citations
16.
Timms, Kirsten M., Susanne Wagner, Mark Samuels, et al.. (2004). A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree. Human Genetics. 114(4). 349–353. 259 indexed citations
17.
Kronenberg, Florian, Hilary Coon, Alexander Gutin, et al.. (2002). A genome scan for loci influencing anti-atherogenic serum bilirubin levels. European Journal of Human Genetics. 10(9). 539–546. 32 indexed citations
18.
Samuels, Mark. (1998). Activities of the Sex-lethal protein in RNA binding and protein:protein interactions. Nucleic Acids Research. 26(11). 2625–2637. 39 indexed citations
19.
Carthew, Richard W., Mark Samuels, & Phillip A. Sharp. (1988). Formation of transcription preinitiation complexes with an amanitin-resistant RNA polymerase II.. Journal of Biological Chemistry. 263(32). 17128–17135. 26 indexed citations
20.
Fire, Andrew, Mark Samuels, & Phillip A. Sharp. (1984). Interactions between RNA polymerase II, factors, and template leading to accurate transcription.. Journal of Biological Chemistry. 259(4). 2509–2516. 230 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefan G. E. Roberts Breakdown of academic impact, for papers by Angabin Matin Breakdown of academic impact, for papers by Vivek Iyer Breakdown of academic impact, for papers by Jonathan D. Chesnut Breakdown of academic impact, for papers by R. E. K. Fournier Breakdown of academic impact, for papers by Roger G. Clerc Breakdown of academic impact, for papers by Chul Geun Kim Breakdown of academic impact, for papers by Francis James Grant Breakdown of academic impact, for papers by Izuho Hatada Breakdown of academic impact, for papers by Vasily Ramensky
Rankless by CCL
2026